Rep. Norm Thurston — Voting Record

Utah House District 62 · complete roll-call record from le.utah.gov
← All votes

Bill

Medicaid Preferred Drug List Amendments
Number
H.B. 18 Second Substitute (2016GS)
Sponsor
Rep. Ward, R.
Final action
House/ filed 3/10/2016
Outcome
Failed / filed without passage

Summary

This bill authorizes the Department of Health to include additional drugs on the Medicaid program's preferred drug list.

What it does

  • This bill:
  • amends definitions;
  • authorizes the Department of Health to consider all psychotropic drugs for inclusion on the Medicaid program's preferred drug list;
  • requires accountable care organizations that contract with Medicaid to pre-authorize psychotropic drugs not on the preferred drug list under certain circumstances;
  • amends the length of the prior authorization to two years;
  • requires the department to report on savings resulting from the preferred drug list;
  • creates the Medicaid Preferred Drug List Restricted Account;
  • requires 40% of the savings attributable to this bill to be deposited into the account;
  • limits use of the account to appropriations to the Department of Human Services; and
  • makes technical amendments.

Every vote on this bill

2/25/2016House/ substituted from # 1 to # 2
House 3rd Reading Calendar for House bills
Voice votenot eligible / no record
2/25/2016House/ circled
House 3rd Reading Calendar for House bills
Voice votenot eligible / no record
2/26/2016House/ uncircled
House 3rd Reading Calendar for House bills
Voice votenot eligible / no record
2/26/2016House/ floor amendment # 2
House 3rd Reading Calendar for House bills
Voice votenot eligible / no record
2/26/2016House/ passed 3rd reading
Senate Secretary
69 2 4YEA

Bill text

introduced version · official source
MEDICAID PREFERRED DRUG LIST AMENDMENTS
GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Raymond P. Ward
Senate Sponsor:
 Allen M. Christensen
LONG TITLE
Committee Note:
The Health and Human Services Interim Committee recommended this bill.
General Description:
This bill authorizes the Department of Health to include additional drugs on the
Medicaid program's preferred drug list.
Highlighted Provisions:
This bill:
▸ amends definitions;
▸ authorizes the Department of Health to consider all psychotropic drugs for inclusion
on the Medicaid program's preferred drug list;
▸ requires accountable care organizations that contract with Medicaid to pre-authorize
psychotropic drugs not on the preferred drug list under certain circumstances;
▸ amends the length of the prior authorization to two years;
▸ requires the department to report on savings resulting from the preferred drug list;
▸ creates the Medicaid Preferred Drug List Restricted Account;
▸ requires 40% of the savings attributable to this bill to be deposited into the account;
▸ limits use of the account to appropriations to the Department of Human Services;
and
▸ makes technical amendments.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
26-18-2.4
, as last amended by Laws of Utah 2012, Chapters 242 and 343
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
26-18-2.4
 is amended to read:
26-18-2.4.
Medicaid drug program -- Preferred drug list.
(1) A Medicaid drug program developed by the department under Subsection
26-18-2.3
(2)(f):
(a) shall, notwithstanding Subsection 
26-18-2.3
(1)(b), be based on clinical and
cost-related factors which include medical necessity as determined by a provider in accordance
with administrative rules established by the Drug Utilization Review Board;
(b) may include therapeutic categories of drugs that may be exempted from the drug
program;
(c) may include placing some drugs, except [
the drugs described
] 
as provided
 in
Subsection (2)
(b)
, on a preferred drug list to the extent determined appropriate by the
department;
(d) notwithstanding the requirements of Part 2, Drug Utilization Review Board, shall
immediately implement [
the
] prior authorization requirements for a nonpreferred drug that is in
the same therapeutic class as a drug that is:
(i) on the preferred drug list on the date that this act takes effect; or
(ii) added to the preferred drug list after this act takes effect; and
(e) except as prohibited by Subsections 
58-17b-606
(4) and (5), shall establish [
the
]
prior authorization requirements [
established
] under [
Subsections (1)(c) and (d) which shall
]
Subsection (1)(d) that:
(i)
 permit a health care provider or the health care provider's agent to obtain a prior
authorization override of the preferred drug list through the department's pharmacy prior
authorization review process[
, and which shall:
]
;
[
(i)
] 
(ii)
 provide either telephone or fax approval or denial of the request within 24
hours of the receipt of a request that is submitted during normal business hours of Monday
through Friday from 8 a.m. to 5 p.m.;
[
(ii)
] 
(iii)
 provide for the dispensing of a limited supply of a requested drug as
determined appropriate by the department in an emergency situation, if the request for an
override is received outside of the department's normal business hours; and
[
(iii)
] 
(iv)
 require the health care provider to provide the department with
documentation of the medical need for the preferred drug list override in accordance with
criteria established by the department in consultation with the 
department's
 Pharmacy and
Therapeutics Committee.
(2) (a) For purposes of this Subsection (2):
(i) "Immunosuppressive drug":
(A) means a drug that is used in immunosuppressive therapy to inhibit or prevent
activity of the immune system to aid the body in preventing the rejection of transplanted organs
and tissue; and
(B) does not include drugs used for the treatment of autoimmune disease or diseases
that are most likely of autoimmune origin.
(ii) "Psychotropic drug" means the following classes of drugs: [
atypical anti-psychotic
]
anti-psychotics
, anti-depressants, anti-convulsant/mood [
stabilizer
] 
stabilizers
, anti-anxiety
drugs
, attention deficit hyperactivity disorder stimulants, or sedative/hypnotics.
(iii) "Stabilized" means a health care provider has documented in the patient's medical
chart that a patient has achieved a stable [
or steadfast
] medical state [
within the past 90 days
using
] 
by use of
 a particular psychotropic drug.
(b) A preferred drug list developed under the provisions of this section may not
include[
: (i) except as provided in Subsection (2)(e), a psychotropic or anti-psychotic drug; or
(ii)
] an immunosuppressive drug.
(c) The [
state
] Medicaid program shall reimburse for a prescription for an
immunosuppressive drug as written by [
the
] 
a
 health care provider for a patient who has
undergone an organ transplant. For purposes of Subsection 
58-17b-606
(4), and with respect to
patients who have undergone an organ transplant, the prescription for a particular
immunosuppressive drug as written by [
a
] 
the
 health care provider meets the criteria of
demonstrating to the [
Department of Health
] 
department
 a medical necessity for dispensing the
prescribed immunosuppressive drug.
(d) Notwithstanding the requirements of Part 2, Drug Utilization Review Board, the
[
state
] Medicaid drug program may not require the use of step therapy for immunosuppressive
drugs without the written or oral consent of the health care provider and the patient.
[
(e) The department may include a sedative hypnotic on a preferred drug list in
accordance with Subsection (2)(f).
]
[
(f)
] 
(e)
 The department shall grant a prior authorization for a [
sedative hypnotic
]
psychotropic drug
 that is not on the preferred drug list [
under Subsection (2)(e),
] if the health
care provider has documentation [
related to
] 
showing at least
 one of the following [
conditions
]
for the Medicaid client:
(i) a trial and failure of at least one preferred agent in the drug class, including the
name of the preferred drug that was tried, the length of therapy, and the reason for the
discontinuation;
(ii) detailed evidence of a potential drug interaction between current medication and
the preferred drug;
(iii) detailed evidence of a condition or contraindication that prevents the use of the
preferred drug;
(iv) objective clinical evidence that a patient is at high risk of adverse events due to a
therapeutic interchange with a preferred drug;
(v) the patient is a new or previous Medicaid client with an existing diagnosis
previously stabilized with a nonpreferred drug; or
(vi) other valid reasons as determined by the department.
[
(g)
] 
(f)
 A prior authorization granted under Subsection (2)[
(f)
]
(e)
 is valid for [
one
year
] 
two years
 from the date the department grants the prior authorization and shall be
renewed in accordance with Subsection (2)[
(f)
]
(e)
.
(g) Accountable care organizations that contract with the state Medicaid program shall
grant prior authorization for a psychotropic drug that is not on the preferred drug list
established by the department if the health care provider has documentation showing at least
one of the conditions listed in Subsections (2)(e)(i) through (vi) for the Medicaid client.
(3) The department shall report to the Health and Human Services Interim Committee
and to the Social Services Appropriations Subcommittee prior to November 1, [
] 
,
regarding the savings to the Medicaid program resulting from the use of [
the
] 
a
 preferred drug
list [
permitted by
] 
developed under
 Subsection (1).
(4) (a) There is created a restricted account within the General Fund called the
"Medicaid Preferred Drug List Restricted Account."
(b) The account consists of savings to the Medicaid program attributable to the
inclusion of psychotropic drugs on the preferred drug list.
(c) Savings to the Medicaid program under Subsection (4)(b) shall be calculated for
each fiscal year by the department.
(d) For each fiscal year, the Legislature shall appropriate to the account an amount
equal to 40% of the savings calculated for the immediately preceding fiscal year, except that
appropriations shall be reduced as necessary to ensure that the account's balance does not
exceed $2,000,000.
(e) Funds from the account may be used only for appropriations by the Legislature to
the Department of Human Services.
Legislative Review Note
Office of Legislative Research and General Counsel